| [1] |
.
[J]. Laboratory Medicine, 2025, 40(3): 306-308.
|
| [2] |
DAI Yao, LI Jiahui, XU Xiuhong.
Prognosis evaluation model of children with Mycoplasma pneumoniae pneumonia based on MP DNA and peripheral blood inflammation indicators
[J]. Laboratory Medicine, 2024, 39(6): 568-572.
|
| [3] |
WANG Huiying, TANG Yu, DONG Lili, WANG Jing.
Role of Mycoplasma pneumoniae RNA determination in diagnosis and efficacy monitoring of pneumonia in children
[J]. Laboratory Medicine, 2023, 38(9): 865-869.
|
| [4] |
HU Shaohua, CHEN Li, ZHAO Meng, MA Zhan, ZHANG Hong.
Epidemiological characteristic analysis of Mycoplasma pneumoniae infection in children in Shanghai
[J]. Laboratory Medicine, 2023, 38(1): 14-17.
|
| [5] |
CHEN Naihan, SA Yalian.
Overview of detection methods for Mycoplasma in cell preparations
[J]. Laboratory Medicine, 2022, 37(7): 684-687.
|
| [6] |
.
[J]. Laboratory Medicine, 2021, 36(2): 202-205.
|
| [7] |
WANG Bingjie, ZHANG Hong.
Research progress of macrolide-resistant Mycoplasma pneumoniae
[J]. Laboratory Medicine, 2020, 35(10): 1070-1074.
|
| [8] |
.
[J]. Laboratory Medicine, 2016, 31(7): 630-631.
|
| [9] |
.
[J]. , 2011, 26(07): 499-500.
|
| [10] |
.
[J]. , 2011, 26(05): 340-342.
|
| [11] |
ZHU Fengcun;ZHOU Liping.
The effect of Mycoplasma penetrans infection on tissue infiltration and metastasis of tumor
[J]. , 2010, 25(02): 113-117.
|
| [12] |
.
[J]. , 2009, 24(08): 590-590.
|
| [13] |
.
[J]. , 2009, 24(04): 250-254.
|
| [14] |
.
[J]. , 2008, 23(05): 542-543.
|
| [15] |
.
[J]. , 2008, 23(04): 443-446.
|
